Evidence map›Paper›PMID 36998080›Full record

ArticleCancer cell international2023

Correction: Camels' biological fluids contained nanobodies: promising avenue in cancer therapy.

Nouf S Al-Numair, Abdulrahman Theyab, Faisal Alzahrani, Anwar M Shams, Ibrahim O Al-Anazi, Atif Abdulwahab A Oyouni, Osama M Al-Amer, Charalampos Mavromatis, Islam M Saadeldin, Wed A Abdali and 1 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer cell international, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Nouf S Al-NumairCenter of Genomic Medicine, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
Abdulrahman TheyabDepartment of Laboratory & Blood Bank, Security Forces Hospital, P.O. Box 14799, Mecca, 21955, Saudi Arabia.
Faisal AlzahraniDepartment of Biochemistry, Faculty of Science, Embryonic Stem Cells Unit, King Fahad Medical Center, King Abdulaziz University, Jeddah, Saudi Arabia.
Anwar M ShamsDepartment of Pharmacology, College of Medicine, Taif University, P.O. BOX 11099, Taif, 21944, Saudi Arabia.
Ibrahim O Al-AnaziThe National Center for Genomic Technology, King Abdulaziz City for Science and Technology, P.O Box 6086, Riyadh, 11442, Saudi Arabia.
Atif Abdulwahab A OyouniDepartment of Biology, Faculty of Sciences, University of Tabuk, Tabuk, Saudi Arabia.
Osama M Al-AmerDepartment of Medical Laboratory Technology, Faculty of Applied Medical Sciences, University of Tabuk, Tabuk, Saudi Arabia.
Charalampos MavromatisDepartment of Biological Sciences, Faculty of Science and Arts (Rabigh Campus), King Abdulaziz University, Jeddah, Saudi Arabia.
Islam M SaadeldinResearch Institute of Veterinary Medicine, Chungam National University, Daejeon, 34134, Korea.
Wed A AbdaliDepartment of Biology, Faculty of Sciences, University of Tabuk, Tabuk, Saudi Arabia.
Yousef M HawsawiCollege of Medicine, Alfaisal University, P.O. Box 50927, Riyadh, 11533, Saudi Arabia. hyousef@kfshrc.edu.sa.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36998080
PMCPMC10064756

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.